hidden title
Available Technologies for Licensing
BCIL offers exciting licensing opportunities for technologies in all key areas of biotechnology and lifesciences including Biotherapeutics, Vaccines, Medical devices and Diagnostics, Transgenics, Plant Varieties etc. The technologies currently available for licensing are given below:
Therapeutic candidates
- Novel Anti-Inflammatory Peptide
- Therapeutic Composition for Quick Healing of Wounds and Associated Inflammation
- Basant-A Novel, Broad spectrum, Clinically Proven Antimicrobial Herbal Formulation
- NAUROZ-A clinically validated, novel technology against Vaginosis
- Novel Small Molecule Combinatorial for treatment of Antibiotic Resistant infection
- Nanomicelles based Effective Drug Delivery System
- Opportunity for licensing ‘Novel Solid Emulsion based Curcumin Formulation with Enhanced Bioavailability’
- An oral anti-diabetic pharmaceutical composition comprising novel synthetic alpha-amylase inhibitor
- Novel compounds as anti-tubercular agents
- A novel method for production turanose from sucrose biomass


Vaccine candidates


Transgenic/Cell-line


Plant Varieties
- Three White Rust Resistant Oilseed Mustard (Brassica juncea) lines:
- Varuna,
- Pusa bold WRR2 and
- Rohini WRR
- DMH-1 hybrid Mustard technology
- Improved Bt-Cotton Technology
Medical Device


Industrial Biotechnology
- A process for production of fructooligosacharides and levan from plant biomass derived feedstock, and uses thereof
- A novel process for the production of the anti-diabetic sugar, D-allulose, by using a D-allulose 3- epimerase of Bacillus sp. Origin.
- A process for the production of trehalose and trehalulose employing a novel trehalose synthase
- Process for production of food-grade dye/colorant powder from flower petals of Butea Monosperma (Lam.) Kuntze (Palash)
Bio-energy
- Method for increasing biomass of Photosynthetic organism by extending its life in Culture
